CYCN insider filings

Cyclerion Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen CYCN transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CYCN between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Cyclerion Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-08-184CHICKO RHONDA M. — Chief Financial OfficerOption exercise (M): 25,000 @ $2.35 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2026-08-184Graul Regina Margaret — See Remarks, DirectorOption exercise (M): 55,849 @ $3.30 · Tax withholding (F): 48,629 @ $3.79 · Option exercise (M): 55,849 (derivative) @ $0EDGAR
2026-07-204Hecht Peter M — Director, 10% ownerConversion (C): 351,037 · Conversion (C): 351,037 (derivative)EDGAR
2025-08-114CHICKO RHONDA M. — Chief Financial OfficerGrant/award (A): 25,000 (derivative) @ $0EDGAR
2025-03-274Higgins Michael J — DirectorGrant/award (A): 9,090 @ $2.75EDGAR
2025-03-274Hecht Peter M — Director, 10% ownerGrant/award (A): 181,818 @ $2.75EDGAR
2024-11-254Slate Path Capital LP — 10% owner
Greenspan David Gerald — 10% owner
Sale (S): 357,880 @ $1.55EDGAR
2024-08-074Graul Regina Margaret — See Remarks, DirectorGrant/award (A): 55,849 (derivative) @ $0EDGAR
2024-01-264Graul Regina Margaret — PresidentGrant/award (A): 50,000 @ $0EDGAR
2024-01-264Hecht Peter M — Director, 10% ownerGrant/award (A): 15,000 @ $0EDGAR
2023-12-044Hyman Steven — DirectorGrant/award (A): 20,000 @ $0EDGAR
2023-12-044Hecht Peter M — Director, 10% ownerGrant/award (A): 20,000 @ $0 · Grant/award (A): 15,000 @ $0EDGAR
2023-12-044DESOUZA ERROL B — DirectorGrant/award (A): 20,000 @ $0 · Grant/award (A): 30,000 @ $0EDGAR
2023-12-044MCGUIRE TERRANCE — DirectorGrant/award (A): 5,000 @ $0EDGAR
2023-08-114MCGUIRE TERRANCE — DirectorSale (S): 8 @ $3.40EDGAR
2023-05-224Hecht Peter M — Chief Executive Officer, Director, 10% ownerGrant/award (A): 225,000 @ $8.68 · Grant/award (A): 351,037 (derivative) @ $8.68EDGAR
2022-07-274/AHyman Steven — DirectorGrant/award (A): 57,753 (derivative) @ $0EDGAR
2022-07-264Hyman Steven — DirectorGrant/award (A): 57,753 (derivative) @ $0EDGAR
2022-06-164Lovell Stephanie — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164Isacson Ole — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164Mendelsohn Michael — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164Fanucci Marsha — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164DESOUZA ERROL B — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164MCGUIRE TERRANCE — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-164CONRADES GEORGE H — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-01-244Busch Andreas — Chief Scientific OfficerGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-01-244Gjino Anjeza — Chief Financial OfficerGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-01-244Gault Cheryl — Chief Operating OfficerGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-01-244Hecht Peter M — Chief Executive Officer, DirectorGrant/award (A): 52,950 (derivative) @ $0 · Grant/award (A): 430,000 (derivative) @ $0EDGAR
2021-12-104Busch Andreas — Chief Scientific OfficerGrant/award (A): 75,000 (derivative) @ $0EDGAR
2021-12-104Gjino Anjeza — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-12-104Gault Cheryl — Chief Operating OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-06-284Lovell Stephanie — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284Isacson Ole — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284Churchwell Kevin — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284Mendelsohn Michael — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284Fanucci Marsha — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284DESOUZA ERROL B — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284MCGUIRE TERRANCE — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-284CONRADES GEORGE H — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-074Slate Path Capital LP — 10% owner
Greenspan David Gerald — 10% owner
Purchase (P): 961,538 @ $3.12EDGAR
2021-06-074Hecht Peter M — Chief Executive Officer, DirectorPurchase (P): 823,170 @ $3.28EDGAR
2021-06-074MCGUIRE TERRANCE — DirectorPurchase (P): 92,831 @ $3.12 · Purchase (P): 3,322 @ $3.12EDGAR
2021-05-104Hecht Peter M — Chief Executive Officer, DirectorPurchase (P): 302,000 @ $2.43EDGAR
2021-05-064Hecht Peter M — Chief Executive Officer, DirectorPurchase (P): 300,000 @ $2.29 · Purchase (P): 398,001 @ $2.53EDGAR
2021-03-014Gjino Anjeza — Chief Financial OfficerSale (S): 1,824 @ $4EDGAR
2021-03-014Wright Christopher I — Chief Medical OfficerSale (S): 2,637 @ $3.99EDGAR
2020-12-304Currie Mark G — President and CSOSale (S): 20,107 @ $3.01EDGAR
2020-11-124Busch Andreas — Chief Innovation OfficerPurchase (P): 125,000 @ $2.53EDGAR
2020-11-104Huyett William — Chief Financial OfficerSale (S): 3,827 @ $2.52EDGAR

Recent 8-K events — Cyclerion Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-118-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.02 — Results of Operations and Financial Condition
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
5.06 — Change in Shell Company Status
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-278-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-258-K8.01 — Other EventsEDGAR
2026-04-018-K1.01 — Entry into a Material Definitive Agreement
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-068-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-018-K8.01 — Other EventsEDGAR
2025-09-238-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CYCN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs